Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study (Q46375297)
Jump to navigation
Jump to search
scientific article published in November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study |
scientific article published in November 2008 |
Statements
1 reference
Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study (English)
1 reference
Ursula Schmidt-Erfurth
1 reference
Gabriela Kornek
1 reference
Wolfgang Geitzenauer
1 reference
Stephan Michels
1 reference
Franz Prager
1 reference
Philip J Rosenfeld
1 reference
Laurenz Vormittag
1 reference
1 November 2008
1 reference
1 reference
28
1 reference
10
1 reference
1375-1386
1 reference